Literature DB >> 22014228

Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.

Maria Tselepi1, Evaggelia Papachristou, Aikaterini Emmanouilidi, Apostolos Angelis, Nektarios Aligiannis, Alexios-Leandros Skaltsounis, Demetrios Kouretas, Kalliopi Liadaki.   

Abstract

Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 μM), human topoisomerase I (IC50: 110-260 μM), and human topoisomerase II (IC50: 240-600 μM) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014228     DOI: 10.1021/np200292u

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  Naturally Occurring Cytotoxic [3'→8″]-Biflavonoids from Podocarpus nakaii.

Authors:  Pen-Ho Yeh; Yun-Dar Shieh; Li-Chun Hsu; Li-Ming Yang Kuo; Jhih-Hu Lin; Chia-Ching Liaw; Yao-Haur Kuo
Journal:  J Tradit Complement Med       Date:  2012-07

2.  Harzianumnones A and B: two hydroxyanthraquinones from the coral-derived fungus Trichoderma harzianum.

Authors:  Ting Shi; Xue-Mei Hou; Zhi-Yong Li; Fei Cao; Ya-Hui Zhang; Jia-Yin Yu; Dong-Lin Zhao; Chang-Lun Shao; Chang-Yun Wang
Journal:  RSC Adv       Date:  2018-08-02       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.